Skip to main content
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.310
+0.020 (0.87%)
At close: Mar 9, 2026, 4:00 PM EDT
2.260
-0.050 (-2.16%)
After-hours: Mar 9, 2026, 7:57 PM EDT

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $1.03M in the quarter ending September 30, 2025, with 67.19% growth. This brings the company's revenue in the last twelve months to $2.86M, up 13.30% year-over-year. In the year 2024, Xenetic Biosciences had annual revenue of $2.50M, down -1.56%.

Revenue (ttm)
$2.86M
Revenue Growth
+13.30%
P/S Ratio
1.85
Revenue / Employee
$1,429,468
Employees
2
Market Cap
5.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.50M-39.70K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.23K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020436.94K419.88K2,460.31%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
GeoVax Labs 3.35M
Cyclerion Therapeutics 2.86M
BioRestorative Therapies 383.40K
VivoSim Labs 142.00K
Bio Green Med Solution 81.00K
Revenue Rankings

XBIO News

More News